Identifying the Primary Tumor Site and Distinguishing False-positives in Patients With Elevated Serum Carcinoembryonic Antigen

Our results suggest the possibility of visually differentiating the primary tumor site in patients with elevated CEA levels. This method may also help recognize false-positive CEA results.

Authors

Institutions

Publication Details

Journal
In Vivo
Published
2025-06-27
DOI
https://doi.org/10.21873/invivo.14035
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identifying the Primary Tumor Site and Distinguishing False-positives in Patients With Elevated Serum Carcinoembryonic Antigen

YUTAKA TAKAHASHI, Hiroaki Satoh, Takashi Sakamoto, Kunihiko Miyazaki et al.
In Vivo
Radiopharmaceutical Chemistry and Applications
article

Identifying the Primary Tumor Site and Distinguishing False-positives in Patients With Elevated Serum Carcinoembryonic Antigen

YUTAKA TAKAHASHI, Hiroaki Satoh, Takashi Sakamoto, Kunihiko Miyazaki, Satoshi Inagawa
article en

Abstract

Our results suggest the possibility of visually differentiating the primary tumor site in patients with elevated CEA levels. This method may also help recognize false-positive CEA results.

In VivoVol. 39(4)
Hamamatsu University School of Medicine (JP), Shirasagi Hospital (JP)
Good health and well-being
Openalex Percentile: Top 77%
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.